The vaccine can be produced at scale and made available to adults and adolescents in countries with a high TB burden

Gates MRI and Serum Institute partner to manufacture a novel TB vaccine, investing $100 million for scalable production.

Serum Institute will manufacture an experimental tuberculosis vaccine. This novel vaccine candidate is currently in late-stage clinical trials. Gates Medical Research Institute…